CD38 and COVID-19: In support of our findings, lymphocyte activation markers such as CD38, CD69, and CD44 are highly expressed on CD4+ and CD8+ T cells of COVID-19 patients (58), and CD73 absence in CD8+ T cells induces granzyme production in these individuals (20).